News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,670 Results
Type
Article (88200)
Company Profile (823)
Press Release (784626)
Multimedia
Podcasts (208)
Webinars (32)
Section
Business (233355)
Career Advice (4152)
Deals (39898)
Drug Delivery (157)
Drug Development (91482)
Employer Resources (205)
FDA (18442)
Job Trends (17442)
News (398145)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (192)
Alzheimer's disease (1829)
Antibody-drug conjugate (ADC) (380)
Approvals (18640)
Artificial intelligence (687)
Autoimmune disease (201)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (490)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (697)
Cancer (5364)
Cardiovascular disease (481)
Career advice (3580)
Career pathing (44)
CAR-T (320)
CDC (68)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (41)
Clinical research (77454)
Collaboration (1972)
Company closure (6)
Compensation (1243)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (976)
Cystic fibrosis (157)
Data (6724)
Decentralized trials (2)
Denatured (77)
Depression (165)
Diabetes (556)
Diagnostics (7332)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (334)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100800)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135937)
Executive appointments (1074)
FDA (21824)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1658)
Gene editing (234)
Generative AI (71)
Gene therapy (722)
GLP-1 (1171)
Government (5485)
Grass and pollen (8)
Guidances (389)
Healthcare (20985)
HIV (76)
Huntington's disease (55)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (135)
Infectious disease (3323)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (100)
Layoffs (664)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (22)
Lung cancer (717)
Lymphoma (397)
Machine learning (49)
Management (66)
Manufacturing (931)
MASH (186)
Medical device (15099)
Medtech (15167)
Mergers & acquisitions (23046)
Metabolic disorders (1487)
mRNA (202)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (390)
Neuropsychiatric disorders (110)
Neuroscience (3263)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (726)
Opinion (349)
Ovarian cancer (176)
Pain (233)
Pancreatic cancer (254)
Parkinson's disease (322)
Partnered (39)
Patents (550)
Patient recruitment (559)
Peanut (65)
People (67184)
Pharmaceutical (144)
Pharmacy benefit managers (34)
Phase 1 (23931)
Phase 2 (33609)
Phase 3 (25319)
Pipeline (6197)
Policy (360)
Postmarket research (3554)
Preclinical (10730)
Press Release (72)
Prostate cancer (273)
Psychedelics (61)
Radiopharmaceuticals (319)
Rare diseases (1025)
Real estate (7445)
Recruiting (81)
Regulatory (29378)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (279)
Series B (207)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1193)
Venture capital (103)
Weight loss (496)
Women's health (106)
Worklife (23)
Date
Today (162)
Last 7 days (796)
Last 30 days (3324)
Last 365 days (32802)
2026 (5986)
2025 (33228)
2024 (38138)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (356)
Arkansas (15)
Asia (51709)
Australia (9085)
California (12262)
Canada (3488)
China (1237)
Colorado (518)
Connecticut (537)
Delaware (363)
Europe (119002)
Florida (1818)
Georgia (398)
Hawaii (4)
Idaho (68)
Illinois (1026)
India (81)
Indiana (576)
Iowa (24)
Japan (471)
Kansas (135)
Kentucky (49)
Louisiana (37)
Maine (85)
Maryland (1523)
Massachusetts (9009)
Michigan (381)
Minnesota (693)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (136)
New Hampshire (88)
New Jersey (3293)
New Mexico (33)
New York (3227)
North Carolina (1691)
North Dakota (10)
Northern California (5931)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2442)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4756)
Tennessee (193)
Texas (1934)
United States (44130)
Utah (370)
Vermont (1)
Virginia (309)
Washington D.C. (88)
Washington State (1015)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,670 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SonoThera Presents New Preclinical Data at MDA 2026 Highlighting RIPPLE™ as an Efficient, Scalable, Nonviral Platform for Full-Length Dystrophin Delivery in DMD
March 5, 2026
·
1 min read
Psychedelics
Psychedelics Are Placeholders for More Traditional Depression Therapies: Analysts
Psychedelics are a “game changer” in depression care, according to William Blair, but the complicated treatment regimens mean they will likely be supplanted by more-traditional options once they become available.
March 5, 2026
·
5 min read
·
Annalee Armstrong
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
The alliance, which pairs Tenaya’s modality agnostic target identification and validation capabilities with Alnylam’s deep experience in RNA interference therapeutics, comes during a period of resurgence for the cardiovascular space.
March 5, 2026
·
2 min read
·
Heather McKenzie
Layoff Tracker
Bayer’s Q4 Cuts Put YOY Drop at About 4,700 Employees
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
March 5, 2026
·
30 min read
·
BioSpace Editorial Staff
Press Releases
Biohacking Index Spotlights Leaders from Functional Longevity Summit
March 5, 2026
·
1 min read
Huntington’s disease
UniQure’s Path for Huntington’s Gene Therapy Clouded by Ethical Questions as Potential Phase 3 Looms
While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be considered for approval, experts believe there is an alternate path forward for the therapy, perhaps even based on precedent from the recent drama surrounding Moderna’s mRNA flu vaccine.
March 5, 2026
·
7 min read
·
Heather McKenzie
Press Releases
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
March 5, 2026
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Live Presentation and Q&A: Monday, March 9, 2026 10 AM EDT CEO to Discuss INTASYL Platform and PH-762 Phase 1b Results
March 5, 2026
·
5 min read
Press Releases
Huonslab Announces Applicable SC delivery for Antibodies and ADCs with ‘HyDIFFUZE™ Platform’
March 5, 2026
·
2 min read
Press Releases
Arcturus Therapeutics to Attend Upcoming March 2026 Investor Conference
March 5, 2026
·
1 min read
1 of 87,367
Next
